Follow-on offering Completed

AbCellera Biologics equity raising

US$200m raised

NASDAQ: ABCL

Advisers

AbCellera Biologics

Issuer

Lead managers

Not disclosed

Issuer
AbCellera Biologics
Issuer based in
Canada
Completed
24 Aug 2026
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.